About Endomag
Endomag is a company based in Cambridge (United Kingdom) founded in 2007 was acquired by Hologic in April 2024.. Endomag has raised $44.52 million across 9 funding rounds from investors including Gov.uk, Hologic and Draper Esprit. Endomag offers products and services including Sentimag, MagseedPro, Magseed, and Magtrace. Endomag operates in a competitive market with competitors including Augmedics, Proprio, eCential Robotics, MRI Interventions and Centerline Biomedical, among others.
- Headquarter Cambridge, United Kingdom
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endomagnetics Ltd
- Date of Incorporation 26 Apr, 2007
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
$22.58 M (USD)19as on Dec 31, 2022
-
Net Profit
$-5.08 M (USD)-34as on Dec 31, 2022
-
EBITDA
$-6.34 M (USD)-19as on Dec 31, 2022
-
Total Equity Funding
$44.52 M (USD)
in 9 rounds
-
Latest Funding Round
$20.7 M (USD), Series D
Nov 24, 2020
-
Investors
Gov.uk
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Hologic
(Apr 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endomag
Endomag offers a comprehensive portfolio of products and services, including Sentimag, MagseedPro, Magseed, and Magtrace. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides magnetic guidance for breast cancer surgery to enhance precision.
Advanced marker for accurate tumor localization in procedures.
Seed device for identifying breast cancer sites during surgery.
Simple tool for breast cancer staging and treatment planning.
Unlock access to complete
Funding Insights of Endomag
Endomag has successfully raised a total of $44.52M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $20.7 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series D — $20.7M
-
First Round
First Round
(03 Jun 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series D - Endomag | Valuation | Draper Esprit | |
| Jul, 2018 | Amount | Series C - Endomag | Valuation | Draper Esprit |
|
| Feb, 2018 | Amount | Grant - Endomag | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endomag
Endomag has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Hologic and Draper Esprit. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic VC firm investing globally
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made by Sussex Place Ventures.
|
Founded Year | Domain | Location | |
|
Online government services and information are provided to users.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endomag
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endomag
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endomag Comparisons
Competitors of Endomag
Endomag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, eCential Robotics, MRI Interventions and Centerline Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| domain | founded_year | HQ Location |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| domain | founded_year | HQ Location |
Robotic surgery platform for bone procedures is developed.
|
|
| domain | founded_year | HQ Location |
MRI-guided minimally invasive procedures for brain and heart are developed.
|
|
| domain | founded_year | HQ Location |
Developer of surgical navigation and image guidance system for endovascular procedures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endomag
Frequently Asked Questions about Endomag
When was Endomag founded?
Endomag was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Endomag located?
Endomag is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Endomag a funded company?
Endomag is a funded company, having raised a total of $44.52M across 9 funding rounds to date.
What is the annual revenue of Endomag?
Annual revenue of Endomag is $22.58M as on Dec 31, 2022.
What does Endomag do?
Endomagnetics has developed a device for tumor identification and detection. The company has developed devices that are Sentimag, a tumor localization system, Magseed markers to localize breast cancer during surgery, and Magtrace lymphatic tracer uses tiny magnetic particles for radiation-free sentinel lymph node biopsies.
Who are the top competitors of Endomag?
Endomag's top competitors include Augmedics, Proprio and ClearPoint Neuro.
What products or services does Endomag offer?
Endomag offers Sentimag, MagseedPro, Magseed, and Magtrace.
Who are Endomag's investors?
Endomag has 4 investors. Key investors include Gov.uk, Hologic, Draper Esprit, and Sussex Place Ventures.
What is Endomag's valuation?
The valuation of Endomag is $117.66M as of Nov 2020.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.